Key result
iASPP overexpression reduces infarct size and improves EF in mice by inhibiting p53-mediated apoptosis.
Answers are grounded in this paper and cite their sources.
Demonstrates that iASPP reduces cardiomyocyte apoptosis and preserves cardiac function in ischemic mice, highlighting a potential therapeutic target for myocardial infarction.
Currently, there remains a great need to elucidate the molecular mechanism of acute myocardial infarction in order to facilitate the development of novel therapy. Inhibitor of apoptosis-stimulating protein of p53 (iASPP) is a member of the ASPP family proteins and an evolutionarily preserved inhibitor of p53 that is involved in many cellular processes, including apoptosis of cancer cells. The purpose of this study was to investigate the possible role of iASPP in acute myocardial infarction. The protein level of iASPP was markedly reduced in the ischemic hearts in vivo and hydrogen peroxide-exposed cardiomyocytes in vitro. Overexpression of iASPP reduced the infarct size and cardiomyocyte apoptosis of mice subjected to 24 h of coronary artery ligation. Echocardiography showed that cardiac function was improved as indicated by the increase in ejection fraction and fractional shortening. In contrast, knockdown of iASPP exacerbated cardiac injury as manifested by impaired cardiac function, increased infarct size, and apoptosis rate. Mechanistically, overexpression of iASPP inhibited, while knockdown of iASPP increased the expressions of p53 and Bax, the key regulators of apoptosis. Taken together, our results suggested that iASPP is an important regulator of cardiomyocyte apoptosis, which represents a potential target in the therapy of myocardial infarction.
No takes yet. Share an insight, caveat, or question.
Yagudin et al. (2020) studied Acute myocardial infarction / myocardial ischemia. iASPP overexpression vs. iASPP knockdown / control was evaluated on Infarct size, cardiomyocyte apoptosis, and cardiac function (ejection fraction and fractional shortening). Overexpression of iASPP reduced infarct size and cardiomyocyte apoptosis while improving ejection fraction in mice after 24 hours of coronary artery ligation by inhibiting p53 and Bax expression.
Synapse has enriched 10 related papers. Consider them for comparative context: